Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 known ✓ | P03372 | 1/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 10/20 | 0.62 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 5/20 | 0.56 |
| ▸ | PPARD | Q03181 | 8/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | LCK | P06239 | 1/20 | 0.54 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.54 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.54 |
| ▸ | PPARG | P37231 | 7/20 | 0.52 |
| ▸ | PPARA | Q07869 | 7/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TLR2 | O60603 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | FABP4 | P15090 | 2/20 | 0.52 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.52 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL27345329 | 1.00 | GPR84 (0.62) | GPR84FFAR1TSHRPPARDMAPT | |
| Cadaverine Tartrate SCHEMBL8331400 | 1.00 | GPR84 (0.62) | GPR84FFAR1TSHRPPARDMAPT | |
| Decane SCHEMBL27602602 | 1.00 | GPR84 (0.62) | GPR84FFAR1TSHRPPARDMAPT | |
| Cadaverine Tartrate SCHEMBL27635614 | 0.97 | GPR84 (0.60) | GPR84FFAR1TSHRPPARDMAPT | |
| Cadaverine Tartrate SCHEMBL27361900 | 0.97 | GPR84 (0.60) | GPR84FFAR1TSHRPPARDMAPT | |
| Cadaverine Tartrate SCHEMBL27745708 | 0.97 | TSHR (0.59) | GPR84FFAR1TSHRPPARDMAPT | |
| Cadaverine Tartrate SCHEMBL6120604 | 0.91 | TSHR (0.59) | GPR84FFAR1TSHRPPARDMAPT | |
| Dodecanol SCHEMBL27941716 | 0.91 | TSHR (0.59) | GPR84FFAR1TSHRPPARDMAPT | |
| Cetostearyl Alcohol SCHEMBL9697588 | 0.91 | TSHR (0.59) | GPR84FFAR1TSHRPPARDMAPT | |
| Myristyl Alcohol SCHEMBL27774125 | 0.91 | TSHR (0.59) | GPR84FFAR1TSHRPPARDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100427484-C | 2-methoxymethyl-3- (3, 4-dichlorophenyl) -8-azabicyclo [3.2.1] octane tartrate | NEUROSEARCH AS (DK) | 2008-10-22 | — | — | CN | claimed |
| CN-1822837-A | 2-methoxymethyl-3- (3, 4-dichlorophenyl) -8-azabicyclo [3.2.1] octane tartrate | NEUROSEARCH AS (DK) | 2006-08-23 | — | — | CN | claimed |
| CN-100427484-C | 2-methoxymethyl-3- (3, 4-dichlorophenyl) -8-azabicyclo [3.2.1] octane tartrate | NEUROSEARCH AS (DK) | 2008-10-22 | — | — | CN | disclosed |
| CN-1822837-A | 2-methoxymethyl-3- (3, 4-dichlorophenyl) -8-azabicyclo [3.2.1] octane tartrate | NEUROSEARCH AS (DK) | 2006-08-23 | — | — | CN | disclosed |
| CN-1046722-C | Heterocyclic compounds and their preparation and use | NOVO NORDISK AS (DK) | 1999-11-24 | — | — | CN | disclosed |
| CN-1040979-C | Antipsychotic method | NOVO NORDISK AS (DK) | 1998-12-02 | — | — | CN | disclosed |
| US-5712287-A | WITH 1,2,5-THIADIAZOLE OR 1,2,5-OXADIAZOLE AZABICYCLIC DERIVATIVES | MUHLHAUSER MARK A (US) | 1998-01-27 | — | — | US | disclosed |
| US-5712271-A | OXADIAZOLE OR THIADIAZOLE COMPOUNDS SUBSTITUTED WITH AZABICYCLO(3.3.1)NONANE RING | MUHLHAUSER MARK A (US) | 1998-01-27 | — | — | US | disclosed |
| US-5710151-A | ADMINISTERING A THIADIAZOLE OR AN OXADIAZOLE DERIVATIVE TO A SUBJECT | MUHLHAUSER MARK A (US) | 1998-01-20 | — | — | US | disclosed |
| US-5679686-A | TREATING SCHIZOPHRENIA BY ADMINISTERING THIADIAZOLE OR OXADIAZOLE DERIVATIVES | NOVO NORDISK A/S (DK) | 1997-10-21 | — | — | US | disclosed |
| US-5677313-A | ADMINISTERING 1,2,5-THIADIAZOLYL-AZABICYCLONONENE DERIVATIVES | NOVO NORDISK A/S (DK) | 1997-10-14 | — | — | US | disclosed |
| EP-0790995-A1 | A METHOD OF TREATING URINARY BLADDER DYSFUNCTIONS | NOVO NORDISK A/S (DK) | 1997-08-27 | — | — | EP | disclosed |
| CN-1133044-A | Antipsychotic method | NOVO NORDISK AS (DK) | 1996-10-09 | — | — | CN | disclosed |
| CN-1121349-A | Heterocyclic compounds and their preparation and use | NOVO NORDISK AS (DK) | 1996-04-24 | — | — | CN | disclosed |
| EP-0470668-A1 | A process for preparing enantiomers of compounds having muscarinic activity | MERCK SHARP & DOHME LTD. (GB) | 1992-02-12 | — | — | EP | disclosed |
| US-5073557-A | Cognition activators, stimulants of central muscarinic acetylc holine receptors | MERCK SHARP & DOHME LIMITED (GB) | 1991-12-17 | — | — | US | disclosed |
| EP-0416754-A2 | A novel substituted pyrazine, formulations thereof and use in medicine | MERCK SHARP & DOHME LTD. (GB) | 1991-03-13 | — | — | EP | disclosed |